Auteur T. GROSHKOVA

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction

S. BYFORD ; B. BARRETT ; N. METREBIAN ; T. GROSHKOVA ; M. CARY ; V. CHARLES ; N. LINTZERIS ; J. STRANG | 2013
Dans British Journal of Psychiatry (Vol.203, n°5, November 2013) Article : Périodique

Background: Despite evidence of the effectiveness of injectable opioid treatment compared with oral methadone for chronic heroin addiction, the additional cost of injectable treatment is considerable, and cost-effectiveness uncertain. Aims: To[...]

Plus d'info

Ajouter à la sélection

Developments in the European cannabis market

OEDT = EMCDDA ; T. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; P. GRIFFITHS ; D. POTTER ; S. CRAFT ; A. ENGLUND ; M. LYNSKEY ; R. SEDEFOV | 2019
Rapport

ENGLISH: This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to in[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Nouveauté

Drug affordability - potential tool for comparing illicit drug markets

T. GROSHKOVA ; A. CUNNINGHAM ; L. ROYUELA ; N. SINGLETON ; T. SAGGERS ; R. SEDEFOV | 2018
Dans International Journal of Drug Policy (Vol.56, June 2018) Article : Périodique

Background: The importance of illicit drug price data and making appropriate adjustments for purity has been repeatedly highlighted for understanding illicit drug markets. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has [...]

Plus d'info

Ajouter à la sélection

Drug squads: units specialised in drug law enforcement in Europe

OEDT = EMCDDA ; L. LANIEL ; R. KASECKER ; T. GROSHKOVA ; C. CARPENTIER | 2013
Rapport

Drug law enforcement activity targets the supply of drugs and is responsible for much of the key data that informs our understanding of drugs supply in Europe. This study looks, for the first time, at how drug law enforcement is organised in Eur[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Nouveauté

Drug supply indicators: Pitfalls and possibilities for improvements to assist comparative analysis

N. SINGLETON ; A. CUNNINGHAM ; T. GROSHKOVA ; L. ROYUELA ; R. SEDEFOV | 2018
Dans International Journal of Drug Policy (Vol.56, June 2018) Article : Périodique

Interventions to tackle the supply of drugs are seen as standard components of illicit drug policies. Therefore drug market-related administrative data, such as seizures, price, purity and drug-related offending, are used in most countries for p[...]

Plus d'info

Ajouter à la sélection

Estimating the size of the drug market - A critical review of approaches used

R. UDRISARD ; C. GRIFFITHS ; P. ESSEIVA ; F. ZOBEL ; T. GROSHKOVA ; A. NOOR | 2023
Chapitre

Both policymakers and the public are interested in the size of the drug market. However, often both the origin and the veracity of estimates made in this area are unclear. To help understand this topic, this chapter summarizes the findings from [...]

Plus d'info

Ajouter à la sélection

Exploring methamphetamine trends in Europe

OEDT = EMCDDA ; J. MOUNTENEY ; T. GROSHKOVA ; D. THANKI ; A. CUNNINGHAM ; M. RYCHERT | 2014
Rapport

Concerns about the availability and use of methamphetamine in Europe have been growing for some time. Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of m[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction

J. STRANG ; T. GROSHKOVA ; A. UCHTENHAGEN ; W. VAN DEN BRINK ; C. HAASEN ; M. T. SCHECHTER ; N. LINTZERIS ; J. BELL ; A. PIRONA ; E. OVIEDO-JOEKES ; R. SIMON ; N. METREBIAN | 2015
Dans British Journal of Psychiatry (Vol.207, n°1, July 2015) Article : Périodique

BACKGROUND: Supervised injectable heroin (SIH) treatment has emerged over the past 15 years as an intensive treatment for entrenched heroin users who have not responded to standard treatments such as oral methadone maintenance treatment (MMT) or[...]

Plus d'info

Ajouter à la sélection

Lien externe

High-risk drug use and new psychoactive substances. Results from an EMCDDA trendspotter study

OEDT = EMCDDA ; J. MOUNTENEY ; M. RUIZ ; A. BO ; T. GROSHKOVA ; J. MATIAS ; L. VANDAM ; F. CARDOSO ; R. CHRISTIE ; L. MONTANARI ; I. GIRAUDON ; P. GRIFFITHS | 2017
Rapport

This report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Increasing potency and price of cannabis in Europe, 2006-16

T. P. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; R. SEDEFOV ; P. GRIFFITHS ; M. T. LYNSKEY | 2019
Dans Addiction (Vol.114, n°6, June 2019) Article : Périodique

ENGLISH: AIMS: To quantify changes in (i) potency (concentration of Delta9-tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value (mg THC/euro) of cannabis resin and herbal cannabis in Europe. DESIGN: Repeated cross-sect[...]

Plus d'info

Ajouter à la sélection

Lien externe

New heroin-assisted treatment. Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond

J. STRANG ; T. GROSHKOVA ; N. METREBIAN | 2012
Rapport

The prescription of substitution drugs, such as methadone and buprenorphine, has become a mainstream, first-line treatment for opioid dependence, with around 700 000 of Europe's 1.3 million problem opioid users receiving substitution treatment t[...]

Plus d'info

Ajouter à la sélection

Lien externe

Documents numériques

Residential treatment for drug use in Europe

OEDT = EMCDDA ; T. GROSHKOVA ; D. HEDRICH ; M. FERRI ; L. MONTANARI | 2014
Rapport

Today, in most European countries, residential treatment programmes form an important element of the range of treatment and rehabilitation options for drug users. The aim of this paper is to provide a Europe-wide overview of the history and avai[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial

J. STRANG ; N. METREBIAN ; N. LINTZERIS ; L. POTTS ; T. CARNWATH ; S. MAYET ; H. WILLIAMS ; D. ZADOR ; R. EVERS ; T. GROSHKOVA ; V. CHARLES ; A. MARTIN ; L. FORZISI | 2010
Dans Lancet (The) (Vol.375, n°9729, May 29, 2010) Article : Périodique

Background: Some heroin addicts persistently fail to benefit from conventional treatments. We aimed to compare the effectiveness of supervised injectable treatment with medicinal heroin (diamorphine or diacetylmorphine) or supervised injectable [...]

Plus d'info

Ajouter à la sélection

The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use [Addiction opinion and debate]

V. LORENZETTI ; C. HINDOCHA ; K. PETRILLI ; P. GRIFFITHS ; J. BROWN ; A. CASTILLO-CARNIGLIA ; J. P. CAULKINS ; A. ENGLUND ; M. A. ElSOHLY ; S. H. GAGE ; T. GROSHKOVA ; A. GUAL ; D. HAMMOND ; W. LAWN ; H. LOPEZ-PELAYO ; J. MANTHEY ; C. MOKRYSZ ; R. L. PACULA ; M. VAN LAAR ; R. VANDREY ; E. WADSWORTH ; A. WINSTOCK ; W. HALL ; H. V. CURRAN ; T. P. FREEMAN | 2022
Dans Addiction (Vol.117, n°6, June 2022) Article : Périodique

BACKGROUND: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use. METH[...]

Plus d'info

Déjà dans votre sélection

Lien externe

Using open-source information to improve the European drug monitoring system

OEDT = EMCDDA ; T. GROSHKOVA ; A. CUNNINGHAM ; N. SINGLETON ; T. STOIAN ; R. SEDEFOV | 2019
Rapport

This paper describes open-source information monitoring and how we use it at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in the area of drug markets - what it is and, importantly, what it is not; the methodology for its [...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique